All amr articles
-
![Germs-with-light-burst-photodisinfection[29]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/2/3/4/10234_germswithlightburstphotodisinfection29_356688_crop.jpg)
NewsExperts call for global action on photodisinfection technology that could prevent thousands of AMR-related deaths
Experts on photodynamic therapy (also known as photodisinfection), have called for greater international recognition of this technology that could replace failing antibiotics and antifungals.
-
NewsNanoplastics can reduce the effectiveness of antibiotics
A study showed that plastic particles not only impair the effect of antibiotics, but could also promote the development of antibiotic-resistant bacteria.
-
OpinionSwimming upstream: the microbial marathon in salmon farming
Is it acceptable to prioritize production over welfare?
-
NewsStructural biology analysis of a Pseudomonas bacterial virus reveals a genome ejection motor
Bacterial viruses, known as phages, are the most abundant biological entities on the planet and are increasingly used as biomedicines to eradicate antibiotic-resistant pathogenic bacteria.
-
NewsChemists pioneer metallodrug-antibiotic combination strategy to combat superbugs
A combination of different types of antibiotics with bismuth-based drugs, such as Pepto-Bismol, disrupts bacterial iron homeostasis, effectively restoring the bactericidal function of multiple antibiotics.
-
NewsBacteria-fighting viruses team up to treat drug-resistant superbugs
Researchers screened a library of bacteriophages to find combinations of the viruses that can work together to fight antibiotic-resistant Klebsiella pneumoniae infections.
-
NewsScientists can pinpoint bacterial needle in haystack using fluorescence
Bacterial troublemakers are able to survive antibiotics and are not detected by diagnostic antibiotic resistance testing. A new method has been developed to look at single bacteria and to find the antibacterial resistant ones, or the troublemakers, among them.
-
NewsResearchers identify likely culprit that turns classical Klebsiella pneumoniae into a drug-resistant killer
A hypervirulent strain of Klebsiella pneumoniae can infect and severely sicken otherwise healthy people. Researchers have identified a likely culprit that is causing the hypervirulence.
-
NewsResearchers identify antibodies against Klebsiella pneumoniae
Researchers have identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections.
-
NewsBioinformatics accurately detects short, fat antibiotic-resistant bacteria
Antibiotic-resistant bacteria exhibit characteristic morphological changes that can be detected microscopically in the absence of antibiotics using a bioinformatics approach.
-
NewsCall for urgent, high-level action to address global scourge of antimicrobial resistance
The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79).
-
NewsScientists develop new method to analyze sewage data for epidemic monitoring
Researchers across Europe have developed a new method for analyzing data from wastewater which can help identify whether disease-causing bacteria, viruses, and antimicrobial resistance come from humans, animals, industry, or the environment.
-
NewsResearchers to study how much MRSA is lurking in the air in hospitals
Scientists are working to minimize health care workers’ exposure to MRSA, or methicillin-resistant Staphylococcus aureus, a type of staph bacteria that’s become resistant to many of the antibiotics used to treat ordinary staph infections.
-
FeaturesRevealing membrane architecture with the ISIS Neutron and Muon Source
How neutron scattering and reflectometry are being used to study membrane interactions and antimicrobial resistance.
-
NewsAMI pitches Government to develop pathway to phage therapy
Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.